Analysis and Perspectives

Dec 01, 2023

Could Amgen’s Biosimilar Wezlana Pose a Challenge to Johnson & Johnson’s Stelara

Nov 29, 2023

Navigating the Booming Cryotherapy Market and Its Future Outlook

Nov 27, 2023

Another Feather in the Cap for Xtandi and Keytruda — The Two Main Cancer Drugs

Nov 24, 2023

Novartis Cosentyx: First Biologic Hidradenitis Suppurativa Treatment After Almost Ten Years

Nov 22, 2023

Innovative Pathways in Joint Reconstruction: Market Dynamics and Future Horizons

Nov 20, 2023

Phathom Secures Dual FDA Approvals for Voquezna Following Impurity Setback

Nov 15, 2023

Evaluating the Growing Role of Rehabilitation Equipment in Revitalizing Lives and Improving the Treatment Outcome

Nov 13, 2023

Servier’s Tibsovo Opens The Door To A New Era In The Battle Against Myelodysplastic Syndromes

Nov 10, 2023

Roche’s Vabysmo Third US Approval Spiced Up the Battle With Regeneron and Bayer’s Eylea

Nov 08, 2023

Glowing Prospects: Energy-Based Aesthetic Devices Market Outlook

Newsletter/Whitepaper